Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Sorafenib for Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization: Retrospective Subgroup Analysis of 2 Prospective Trials

Purpose:Sorafenib is recommended for patients with hepatocellular carcinoma refractory to transarterial chemoembolization but with unsatisfactory overall survival and tumor response rate. Previously published studies showed hepatic arterial infusion chemotherapy of oxaliplatin, fluorouracil, and leu...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, YeXing, Zhang, LiHong, He, MinKe, Lai, ZhiCheng, Bu, XiaoYun, Wen, DongSheng, Li, QiJiong, Xu, Li, Wei, Wei, Zhang, YaoJun, Zhou, ZhongGuo, Chen, MinShan, Guo, RongPing, Shi, Ming, Kan, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772936/
https://www.ncbi.nlm.nih.gov/pubmed/36529949
http://dx.doi.org/10.1177/15330338221117389

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772936/
https://www.ncbi.nlm.nih.gov/pubmed/36529949
http://dx.doi.org/10.1177/15330338221117389

Ejemplares similares